Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma (NAMSW) Change in Acquisitions & Divestments (2025)

Historic Change in Acquisitions & Divestments for NewAmsterdam Pharma (NAMSW) over the last 1 years, with Q3 2025 value amounting to $34.4 million.